ARCHIVES

Rep. Wyden Questions NCI Motive For Choosing Not To Pursue RU 486

This article is from The Cancer Letter archive.

Vol. 18 No. 34 | September 4, 1992

Download PDF Visit The Full Archive

Related Articles

Gynecologic Oncology Group To Conduct Phase III Trial of Xyotax For Ovarian Cancer

April 30, 2004

Reorganization Of Making Program Is Proposed

June 22, 1990

New Concepts Being Developed By Organ Systems Groups Described

January 2, 1987

NIH director would have broad authority over institute budgets in proposed bill.

July 22, 2005

FDA Names Director Of New Center For Tobacco Products

September 11, 2009

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

September 11, 1998